Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)

DSpace Repository

Show simple item record

dc.contributor.author Fierlbeck, Gerhard
dc.date.accessioned 2020-02-10T08:12:26Z
dc.date.available 2020-02-10T08:12:26Z
dc.date.issued 2018
dc.identifier.issn 1468-2060
dc.identifier.uri http://hdl.handle.net/10900/97732
dc.language.iso en de_DE
dc.publisher Bmj Publishing Group de_DE
dc.relation.uri http://dx.doi.org/10.1136/annrheumdis-2017-211682
dc.subject.ddc 610 de_DE
dc.title Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate) de_DE
dc.type Article de_DE
utue.quellen.id 20190321153956_03904
utue.publikation.seiten 212-220 de_DE
utue.personen.roh Khanna, Dinesh
utue.personen.roh Denton, Christopher P.
utue.personen.roh Lin, Celia J. F.
utue.personen.roh van Laar, Jacob M.
utue.personen.roh Frech, Tracy M.
utue.personen.roh Anderson, Marina E.
utue.personen.roh Baron, Murray
utue.personen.roh Chung, Lorinda
utue.personen.roh Fierlbeck, Gerhard
utue.personen.roh Lakshminarayanan, Santhanam
utue.personen.roh Allanore, Yannick
utue.personen.roh Pope, Janet E.
utue.personen.roh Riemekasten, Gabriela
utue.personen.roh Steen, Virginia
utue.personen.roh Mueller-Ladner, Ulf
utue.personen.roh Spotswood, Helen
utue.personen.roh Burke, Laura
utue.personen.roh Siegel, Jeffrey
utue.personen.roh Jahreis, Angelika
utue.personen.roh Furst, Daniel E.
dcterms.isPartOf.ZSTitelID Annals of The Rheumatic Diseases de_DE
dcterms.isPartOf.ZS-Issue 2 de_DE
dcterms.isPartOf.ZS-Volume 77 de_DE
utue.fakultaet Universität Tübingen (ohne Fakultätsangabe)


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record